Logo image of RGEN

REPLIGEN CORP (RGEN) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:RGEN - US7599161095 - Common Stock

160.05 USD
-3.58 (-2.19%)
Last: 1/28/2026, 8:12:14 PM
160.05 USD
0 (0%)
After Hours: 1/28/2026, 8:12:14 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RGEN revenue by date.RGEN revenue by date.
801.5M
19.54%
632.362M
-21.10%
634.439M
0.33%
747.78M
17.86%
840.81M
12.44%
966.04M
14.89%
1.139B
17.90%
1.354B
18.88%
1.642B
21.27%
2.015B
22.72%
2.444B
21.29%
2.947B
20.58%
EBITDA
YoY % growth
RGEN ebitda by date.RGEN ebitda by date.
247M
14.25%
147.988M
-40.09%
81.728M
-44.77%
141.36M
72.96%
172.25M
21.85%
215.11M
24.88%
300.43M
39.66%
371.65M
23.71%
464.7M
25.04%
496.27M
6.79%
580.33M
16.94%
688.52M
18.64%
EBIT
YoY % growth
RGEN ebit by date.RGEN ebit by date.
196M
10.24%
79.903M
-59.23%
12.055M
-84.91%
90.358M
649.55%
117.54M
30.08%
168.59M
43.43%
245.72M
45.75%
327.37M
33.23%
438.4M
33.92%
502.76M
14.68%
626.99M
24.71%
774.28M
23.49%
Operating Margin
RGEN operating margin by date.RGEN operating margin by date.
24.45%12.64%1.90%12.08%13.98%17.45%21.57%24.18%26.70%24.95%25.65%26.27%
EPS
YoY % growth
RGEN eps by date.RGEN eps by date.
3.28
7.19%
1.73
-47.26%
1.48
-14.45%
1.70
14.84%
2.11
24.00%
2.70
28.27%
3.61
33.40%
4.43
22.98%
5.46
23.05%
5.54
1.50%
6.68
20.63%
8.05
20.46%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.45
1.93%
0.46
16.80%
0.50
35.67%
0.54
17.54%
0.61
34.90%
0.65
43.31%
0.68
34.78%
0.74
36.46%
0.79
30.94%
Revenue
Q2Q % growth
196.77M
17.44%
194.86M
15.18%
207.67M
13.88%
212.35M
12.47%
223.24M
13.45%
226.66M
16.32%
238.53M
14.86%
242.02M
13.97%
249.97M
11.97%
EBITDA
Q2Q % growth
37.86M
-49.38%
38.121M
39.87%
41.54M
-24.26%
43.768M
-42.12%
49.003M
29.43%
49.995M
31.15%
51.133M
23.09%
55.452M
26.70%
59.425M
21.27%
EBIT
Q2Q % growth
25.069M
389.34%
25.135M
193.94%
28.657M
78.46%
30.947M
83.93%
37.027M
47.70%
40.29M
60.29%
41.432M
44.58%
45.808M
48.02%
49.781M
34.45%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.46
6.98%
0.430.037.78%
Q2 2025
Q2Q % growth
0.37
12.12%
0.40-0.03-6.83%
Q1 2025
Q2Q % growth
0.39
39.29%
0.350.0410.73%
Q4 2024
Q2Q % growth
0.44
33.33%
0.420.025.21%
Q3 2024
Q2Q % growth
0.43
86.96%
0.340.0925.89%
Q2 2024
Q2Q % growth
0.33
-37.74%
0.330.00-0.80%
Q1 2024
Q2Q % growth
0.28
-56.25%
0.31-0.03-9.00%
Q4 2023
Q2Q % growth
0.33
-51.47%
0.330.00-0.62%
Q3 2023
Q2Q % growth
0.23
-70.13%
0.170.0635.96%
Q2 2023
Q2Q % growth
0.53
-41.76%
0.480.059.34%
Q1 2023
Q2Q % growth
0.64
-30.43%
0.600.046.89%
Q4 2022
Q2Q % growth
0.68
-16.05%
0.590.0915.49%
Q3 2022
Q2Q % growth
0.77
-1.28%
0.690.0811.01%
Q2 2022
Q2Q % growth
0.91
15.19%
0.730.1824.49%
Q1 2022
Q2Q % growth
0.92
35.29%
0.730.1925.27%
Q4 2021
Q2Q % growth
0.81
55.77%
0.660.1522.41%
Q3 2021
Q2Q % growth
0.78
95.00%
0.650.1320.19%
Q2 2021
Q2Q % growth
0.79
88.10%
0.530.2647.88%
Q1 2021
Q2Q % growth
0.68
112.50%
0.430.2557.79%
Q4 2020
Q2Q % growth
0.52 0.310.2166.47%
Q3 2020
Q2Q % growth
0.40 0.280.1241.94%
Q2 2020
Q2Q % growth
0.42 0.280.1450.12%
Q1 2020
Q2Q % growth
0.32 0.230.0941.80%
RGEN Yearly EPS VS EstimatesRGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
188.805M
21.94%
184.97M3.835M2.07%
Q2 2025
Q2Q % growth
182.366M
18.36%
178.52M3.846M2.15%
Q1 2025
Q2Q % growth
169.172M
11.80%
167.11M2.062M1.23%
Q4 2024
Q2Q % growth
167.547M
7.58%
171.02M-3.473M-2.03%
Q3 2024
Q2Q % growth
154.834M
9.66%
156.29M-1.456M-0.93%
Q2 2024
Q2Q % growth
154.073M
-3.20%
157.2M-3.127M-1.99%
Q1 2024
Q2Q % growth
151.31M
-17.16%
153.06M-1.75M-1.14%
Q4 2023
Q2Q % growth
155.743M
-16.63%
158.49M-2.747M-1.73%
Q3 2023
Q2Q % growth
141.192M
-29.65%
143.46M-2.268M-1.58%
Q2 2023
Q2Q % growth
159.169M
-23.33%
169.24M-10.071M-5.95%
Q1 2023
Q2Q % growth
182.66M
-11.50%
185.06M-2.4M-1.30%
Q4 2022
Q2Q % growth
186.8M
0.16%
188.25M-1.45M-0.77%
Q3 2022
Q2Q % growth
200.7M
12.63%
195.33M5.37M2.75%
Q2 2022
Q2Q % growth
207.6M
27.36%
193.12M14.48M7.50%
Q1 2022
Q2Q % growth
206.4M
44.54%
189.19M17.21M9.10%
Q4 2021
Q2Q % growth
186.5M
71.73%
182.88M3.62M1.98%
Q3 2021
Q2Q % growth
178.2M
89.37%
167.25M10.95M6.55%
Q2 2021
Q2Q % growth
163M
86.29%
147.13M15.87M10.79%
Q1 2021
Q2Q % growth
142.8M
87.65%
119.35M23.45M19.65%
Q4 2020
Q2Q % growth
108.6M 95.754M12.846M13.42%
Q3 2020
Q2Q % growth
94.1M 88.178M5.922M6.72%
Q2 2020
Q2Q % growth
87.5M 79.948M7.552M9.45%
Q1 2020
Q2Q % growth
76.1M 72.612M3.488M4.80%
RGEN Yearly Revenue VS EstimatesRGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B 2.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.29% -11.74% 0% -1.07%
Revenue0.1% -0.16% 0.02% 0.92%